I
Ithaar Derweesh
Researcher at University of California, San Diego
Publications - 384
Citations - 10873
Ithaar Derweesh is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Nephrectomy & Medicine. The author has an hindex of 38, co-authored 273 publications receiving 8647 citations. Previous affiliations of Ithaar Derweesh include University of California, Irvine & UC San Diego Health System.
Papers
More filters
Journal ArticleDOI
Guideline for management of the clinical T1 renal mass.
Steven C. Campbell,Andrew C. Novick,Arie S. Belldegrun,Michael L. Blute,George K. Chow,Ithaar Derweesh,Martha M. Faraday,Jihad H. Kaouk,Raymond J. Leveillee,Surena F. Matin,Paul Russo,Robert G. Uzzo +11 more
Journal ArticleDOI
Renal Mass and Localized Renal Cancer: AUA Guideline
Steven C. Campbell,Robert G. Uzzo,Mohamad E. Allaf,Eric B Bass,Jeffrey A. Cadeddu,Anthony Chang,Peter E. Clark,Brian J. Davis,Ithaar Derweesh,Leo Giambarresi,Debra A. Gervais,Susie L. Hu,Brian R. Lane,Bradley C. Leibovich,Philip M. Pierorazio +14 more
TL;DR: Several factors should be considered during counseling/management of patients with clinically localized renal masses, including general health/comorbidities, oncologic potential of the mass, pertinent functional issues and relative efficacy/potential morbidities of various management strategies.
Journal ArticleDOI
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J. Motzer,Eric Jonasch,Neeraj Agarwal,Sam B. Bhayani,William P Bro,Sam S. Chang,Toni K. Choueiri,Brian A. Costello,Ithaar Derweesh,Mayer Fishman,Thomas H. Gallagher,John L. Gore,Steven L. Hancock,Michael R. Harrison,Won Kim,Christos Kyriakopoulos,Chad A. LaGrange,Elaine T. Lam,Clayton Lau,M. Dror Michaelson,Thomas Olencki,Phillip M. Pierorazio,Elizabeth R. Plimack,Bruce G. Redman,Brian Shuch,Brad Somer,Guru Sonpavde,Jeffrey A. Sosman,Mary A. Dwyer,Rashmi Kumar +29 more
TL;DR: The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma.
Journal ArticleDOI
Featured Updates to the NCCN Guidelines
Robert J. Motzer,Eric Jonasch,M. Dror Michaelson,Lakshminarayanan Nandagopal,John L. Gore,Saby George,Ajjai Alva,Naomi B. Haas,Michael R. Harrison,Elizabeth R. Plimack,Jeffrey A. Sosman,Neeraj Agarwal,Sam B. Bhayani,Toni K. Choueiri,Brian A. Costello,Ithaar Derweesh,Thomas H. Gallagher,Steven L. Hancock,Christos Kyriakopoulos,Chad A. LaGrange,Elaine T. Lam,Clayton Lau,Bryan Lewis,Brandon Manley,Brittany McCreery,Andrew McDonald,Amir Mortazavi,Phillip M. Pierorazio,Lee Ponsky,Bruce G. Redman,Bradley G. Somer,Geoffrey Wile,Mary A. Dwyer,Lydia J. Hammond,Griselda Zuccarino-Catania +34 more
TL;DR: The major changes to the 2012 and 2011 NCCN Guidelines for Soft Tissue Sarcoma pertain to the management of patients with gastrointestinal stromal tumors and desmoid tumors.
Journal ArticleDOI
Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Maria Carmen Mir,Ithaar Derweesh,Francesco Porpiglia,Homayoun Zargar,Alexandre Mottrie,Riccardo Autorino +5 more
TL;DR: PN is a viable treatment option for larger renal tumors, as it offers acceptable surgical morbidity, equivalent cancer control, and better preservation of renal function, with potential for better long-term survival.